You are here

Home ยป Company Details

ARAVASC, INC.

Company Information
Address
1520 Samedra St
Sunnyvale, CA 94087-4113
United States
Information

UEI: C5QVPEJYM4K8

# of Employees: 3
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: Yes

Woman Owned: Yes

Award Charts




Award Listing

  • Record 1 TO 4

  1. SBIR PHASE I AWARD

    Amount: $200,000.00

    Esophageal cancer is a deadly disease with limited treatment options. In addition to modest effects, toxic chemo-therapy drugs cripple patients with debilitating side-effects. This proposal utilizes a ...

    SBIRPhase I2011Department of Health and Human Services National Institutes of Health

  2. MULTIFUNCTIONAL DRUG-DELIVERY STENT WITH NANOPOROUS COAT

    Amount: $199,999.00

    The overall long-term objective of this proposal is to develop a loco-regional multi-functional theranostic delivery system (MTDS) to treat lung cancer in patients with focal disease, as an adjunct to ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health

  3. Drug-eluting Tracheobronchial Stents to treat Obstruction caused by Lung Cancer

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Airways can be obstructed by a variety of diseases resulting in breathing difficulties and compromised quality of life for the patients. Lung cancer is one of the ...

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health

  4. SBIR Phase I: Drug Eluting Stents to Treat Obstructed Tracheo-Bronchial Lumen Due to Lung Cancer

    Amount: $100,000.00

    This Small Business Innovation Research (SBIR) Phase I research project will demonstrate the feasibility of developing a tracheobronchial drug eluting stent (DES) by coating a biodegradable polymeric ...

    SBIRPhase I2006National Science Foundation
US Flag An Official Website of the United States Government